156 related articles for article (PubMed ID: 23177082)
21. CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America.
Araque M; Millán B; Mendoza E; Salas M
J Infect Dev Ctries; 2013 May; 7(5):432-5. PubMed ID: 23669435
[No Abstract] [Full Text] [Related]
22. Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains.
Adamus-Białek W; Wawszczak M; Arabski M; Majchrzak M; Gulba M; Jarych D; Parniewski P; Głuszek S
Virulence; 2019 Dec; 10(1):260-276. PubMed ID: 30938219
[TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.
Croxall G; Hale J; Weston V; Manning G; Cheetham P; Achtman M; McNally A
J Antimicrob Chemother; 2011 Nov; 66(11):2501-8. PubMed ID: 21862477
[TBL] [Abstract][Full Text] [Related]
24. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity data in support of nitrofurantoin three times per day.
Amábile-Cuevas CF; Arredondo-García JL
J Antimicrob Chemother; 2011 Jul; 66(7):1652-3. PubMed ID: 21525023
[No Abstract] [Full Text] [Related]
26. Coping with a stressful host.
Thumbikat P
Virulence; 2011; 2(3):175-6. PubMed ID: 21597321
[No Abstract] [Full Text] [Related]
27. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
[No Abstract] [Full Text] [Related]
28. Uropathogenic Escherichia coli infection: potential importance of epigenetics.
Tolg C; Bägli DJ
Epigenomics; 2012 Apr; 4(2):229-35. PubMed ID: 22449193
[TBL] [Abstract][Full Text] [Related]
29. Non-lactose-fermenting uropathogenic Escherichia coli from dogs: virulence profile characterization.
Siqueira FM; De Carli S; Lopes CE; Machado L; Vieira TR; Pöppl ÁG; Cardoso MRI; Zaha A
Lett Appl Microbiol; 2021 May; 72(5):596-603. PubMed ID: 33524173
[TBL] [Abstract][Full Text] [Related]
30. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?
Marrs CF; Zhang L; Foxman B
FEMS Microbiol Lett; 2005 Nov; 252(2):183-90. PubMed ID: 16165319
[TBL] [Abstract][Full Text] [Related]
31. O-serogroups of multi-drug resistant cervicovaginal Escherichia coli harboring a battery of virulence genes.
Paniagua-Contreras GL; Monroy-Pérez E; Solis RR; Cerón AB; García Cortés LR; Alonso NN; Camarillo DH; Arreygue LS; Domínguez-Trejo P; Velásquez CD; Vaca-Paniagua F; Uribe-García A; Vaca S
J Infect Chemother; 2019 Jul; 25(7):494-497. PubMed ID: 30824302
[TBL] [Abstract][Full Text] [Related]
32. Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends.
Ghosh A; Bandyopadhyay D; Koley S; Mukherjee M
Appl Biochem Biotechnol; 2021 Jul; 193(7):2267-2296. PubMed ID: 33595784
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of class 1 integrons in uropathogenic fluoroquinolone-resistant clinical Escherichia coli isolates from Jamaica.
Stephenson SA; Brown PD
APMIS; 2013 Mar; 121(3):226-31. PubMed ID: 23030058
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of adhesive genes among uropathogenic Escherichia coli strains isolated from patients with urinary tract infection in Mangalore.
Shetty AV; Kumar SH; Shekar M; Shetty AK; Karunasagar I; Karunasagar I
Indian J Med Microbiol; 2014; 32(2):175-8. PubMed ID: 24713907
[TBL] [Abstract][Full Text] [Related]
35. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis.
Guglietta A
Future Microbiol; 2017 Mar; 12():239-246. PubMed ID: 28262045
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis.
Hadifar S; Moghoofei M; Nematollahi S; Ramazanzadeh R; Sedighi M; Salehi-Abargouei A; Miri A
Jpn J Infect Dis; 2017 Jan; 70(1):19-25. PubMed ID: 27000462
[TBL] [Abstract][Full Text] [Related]
37. Comparison of virulence variations on MDCK monolayers by Escherichia coli isolated from acute lobar nephronia and acute pyelonephritis.
Cheng CH; Su LH; Tsau YK; Lin TY
New Microbiol; 2011 Jan; 34(1):65-72. PubMed ID: 21344148
[TBL] [Abstract][Full Text] [Related]
38. An exploratory study of dog park visits as a risk factor for exposure to drug-resistant extra-intestinal pathogenic E. coli (ExPEC).
Ahmed LN; Price LB; Graham JP
BMC Res Notes; 2015 Apr; 8():137. PubMed ID: 25886556
[TBL] [Abstract][Full Text] [Related]
39. The use of infrared spectroscopy and artificial neural networks for detection of uropathogenic Escherichia coli strains' susceptibility to cephalothin.
Lechowicz L; Urbaniak M; Adamus-Białek W; Kaca W
Acta Biochim Pol; 2013; 60(4):713-8. PubMed ID: 24432322
[TBL] [Abstract][Full Text] [Related]
40. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
